| UniProt ID | MED27_HUMAN | |
|---|---|---|
| UniProt AC | Q6P2C8 | |
| Protein Name | Mediator of RNA polymerase II transcription subunit 27 | |
| Gene Name | MED27 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 311 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.. | |
| Protein Sequence | MADVINVSVNLEAFSQAISAIQALRSSVSRVFDCLKDGMRNKETLEGREKAFIAHFQDNLHSVNRDLNELERLSNLVGKPSENHPLHNSGLLSLDPVQDKTPLYSQLLQAYKWSNKLQYHAGLASGLLNQQSLKRSANQMGVSAKRRPKAQPTTLVLPPQYVDDVISRIDRMFPEMSIHLSRPNGTSAMLLVTLGKVLKVIVVMRSLFIDRTIVKGYNENVYTEDGKLDIWSKSNYQVFQKVTDHATTALLHYQLPQMPDVVVRSFMTWLRSYIKLFQAPCQRCGKFLQDGLPPTWRDFRTLEAFHDTCRQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 26 | Phosphorylation | SAIQALRSSVSRVFD HHHHHHHHHHHHHHH | 35.62 | 21406692 | |
| 27 | Phosphorylation | AIQALRSSVSRVFDC HHHHHHHHHHHHHHH | 20.06 | 21406692 | |
| 29 | Phosphorylation | QALRSSVSRVFDCLK HHHHHHHHHHHHHHH | 25.36 | 19664994 | |
| 36 | Ubiquitination | SRVFDCLKDGMRNKE HHHHHHHHHHHCCHH | 59.58 | - | |
| 36 | Acetylation | SRVFDCLKDGMRNKE HHHHHHHHHHHCCHH | 59.58 | 26051181 | |
| 42 | Ubiquitination | LKDGMRNKETLEGRE HHHHHCCHHHHCHHH | 41.53 | - | |
| 50 (in isoform 2) | Ubiquitination | - | 47.43 | 21890473 | |
| 50 (in isoform 1) | Ubiquitination | - | 47.43 | 21890473 | |
| 50 | Ubiquitination | ETLEGREKAFIAHFQ HHHCHHHHHHHHHHH | 47.43 | 21890473 | |
| 79 (in isoform 2) | Ubiquitination | - | 37.58 | 21890473 | |
| 79 (in isoform 1) | Ubiquitination | - | 37.58 | 21890473 | |
| 79 | Ubiquitination | RLSNLVGKPSENHPL HHHHHCCCCCCCCCC | 37.58 | 21906983 | |
| 100 | Ubiquitination | SLDPVQDKTPLYSQL CCCCCCCCCCHHHHH | 34.64 | - | |
| 104 | Phosphorylation | VQDKTPLYSQLLQAY CCCCCCHHHHHHHHH | 8.79 | 27642862 | |
| 112 (in isoform 2) | Ubiquitination | - | 47.35 | 21890473 | |
| 112 (in isoform 1) | Ubiquitination | - | 47.35 | 21890473 | |
| 112 | Ubiquitination | SQLLQAYKWSNKLQY HHHHHHHHHCCHHHH | 47.35 | 21890473 | |
| 116 | Ubiquitination | QAYKWSNKLQYHAGL HHHHHCCHHHHHHHH | 31.30 | 21890473 | |
| 116 (in isoform 2) | Ubiquitination | - | 31.30 | 21890473 | |
| 116 (in isoform 1) | Ubiquitination | - | 31.30 | 21890473 | |
| 119 | Phosphorylation | KWSNKLQYHAGLASG HHCCHHHHHHHHHHH | 12.22 | 24117733 | |
| 125 | Phosphorylation | QYHAGLASGLLNQQS HHHHHHHHHHCCHHH | 34.71 | 24117733 | |
| 132 | Phosphorylation | SGLLNQQSLKRSANQ HHHCCHHHHHHHHHH | 26.54 | 22199227 | |
| 134 | Methylation | LLNQQSLKRSANQMG HCCHHHHHHHHHHHC | 49.94 | 24129315 | |
| 134 | Ubiquitination | LLNQQSLKRSANQMG HCCHHHHHHHHHHHC | 49.94 | 21906983 | |
| 134 (in isoform 2) | Ubiquitination | - | 49.94 | 21890473 | |
| 134 (in isoform 1) | Ubiquitination | - | 49.94 | 21890473 | |
| 145 (in isoform 2) | Ubiquitination | - | 41.24 | 21890473 | |
| 145 | Acetylation | NQMGVSAKRRPKAQP HHHCCCCCCCCCCCC | 41.24 | 25953088 | |
| 145 (in isoform 1) | Ubiquitination | - | 41.24 | 21890473 | |
| 145 | Ubiquitination | NQMGVSAKRRPKAQP HHHCCCCCCCCCCCC | 41.24 | 21906983 | |
| 177 | Phosphorylation | DRMFPEMSIHLSRPN HHHCCCCEEEECCCC | 12.75 | - | |
| 181 | Phosphorylation | PEMSIHLSRPNGTSA CCCEEEECCCCCCCH | 31.37 | - | |
| 215 | Ubiquitination | FIDRTIVKGYNENVY CCCCHHHCCCCCCCC | 52.40 | 21906983 | |
| 215 (in isoform 1) | Ubiquitination | - | 52.40 | 21890473 | |
| 222 | Phosphorylation | KGYNENVYTEDGKLD CCCCCCCCCCCCCEE | 18.92 | - | |
| 227 | Ubiquitination | NVYTEDGKLDIWSKS CCCCCCCCEEEEECC | 56.14 | 21906983 | |
| 227 (in isoform 1) | Ubiquitination | - | 56.14 | 21890473 | |
| 232 | Phosphorylation | DGKLDIWSKSNYQVF CCCEEEEECCCHHHH | 26.92 | - | |
| 233 (in isoform 1) | Ubiquitination | - | 27.94 | 21890473 | |
| 233 | Ubiquitination | GKLDIWSKSNYQVFQ CCEEEEECCCHHHHH | 27.94 | 21890473 | |
| 234 | Phosphorylation | KLDIWSKSNYQVFQK CEEEEECCCHHHHHH | 34.94 | - | |
| 236 | Phosphorylation | DIWSKSNYQVFQKVT EEEECCCHHHHHHHC | 17.10 | - | |
| 239 (in isoform 2) | Ubiquitination | - | 3.25 | 21890473 | |
| 243 | Phosphorylation | YQVFQKVTDHATTAL HHHHHHHCHHHHHHH | 29.15 | - | |
| 275 (in isoform 1) | Ubiquitination | - | 34.71 | 21890473 | |
| 275 | Ubiquitination | TWLRSYIKLFQAPCQ HHHHHHHHHHHHHHH | 34.71 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MED27_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MED27_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MED27_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MED4_HUMAN | MED4 | physical | 22939629 | |
| SUH_HUMAN | RBPJ | physical | 21988832 | |
| SOX5_HUMAN | SOX5 | physical | 21988832 | |
| MED12_HUMAN | MED12 | physical | 26344197 | |
| MED16_HUMAN | MED16 | physical | 26344197 | |
| MED17_HUMAN | MED17 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...